0001127602-15-011916.txt : 20150318 0001127602-15-011916.hdr.sgml : 20150318 20150318173959 ACCESSION NUMBER: 0001127602-15-011916 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150317 FILED AS OF DATE: 20150318 DATE AS OF CHANGE: 20150318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 15711048 MAIL ADDRESS: STREET 1: 55 TW ALEXANDER DRIVE STREET 2: PO BOX 14186 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-03-17 0001082554 UNITED THERAPEUTICS Corp UTHR 0001627642 ZACCARDELLI DAVID C/O UNITED THERAPEUTICS CORP. 1040 SPRING STREET SILVER SPRING MD 20910 1 EVP & Chief Operating Officer Common Stock 2015-03-17 4 M 0 4000 47.50 A 5153 D Common Stock 2015-03-17 4 S 0 4000 177.34 D 1153 D Share Tracking Award 47.50 2015-03-17 4 M 0 4000 0 D 2013-03-15 2022-03-15 Common Stock 4000 17500 D Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2015-03-18